Effect of Hematocrit Injury on the Survival Rate of Advanced Malignant Tumors and Its Clinical Significance

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2022 Jun 27

PMID 35756408

Authors

Lin Li

Weibin Wu

Mingdi Yin

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effect of logistic multivariate analysis on the survival rate of advanced malignant tumors and to evaluate the effect of erythrocyte storage injury on the survival rate of advanced malignant tumors and its clinical significance.

Methods: A retrospective analysis was performed on 120 advanced cancer patients who received blood transfusion in Shaanxi Cancer Hospital from March 2018 to June 2019, and the risk factors for death were analyzed. A total of 72 advanced cancer patients admitted to hospital from March 2019 to June 2021 were included in the study. The patients with red blood cell transfusion storage time ≤ 14 d were the study group ( = 36), and the patients with red blood cell transfusion storage time > 14 d were the control group ( = 36). Compare the total efficiency of blood transfusion. The levels of Hb, erythrocyte count, hematocrit (HCT), blood oxygen saturation (SPO2), creatinine (Cr), erythrocyte deformability index, whole blood, erythrocyte, and hemoglobin before and after blood transfusion were compared, and the adverse reactions of blood transfusion were recorded.

Results: Dyspnea and delirium were significantly associated with patient survival time ( < 0.05). Red blood cell storage time ≤ 14 days, Lym% < 12%, lactate dehydrogenase (LDH) > 500 U/L, and ALB < 30 g/L were significantly correlated with survival time. Karnofsky performance status (KPS) < 30, delirium, LDH > 500 U/L, and albumin (ALB) < 30 g/L were independent influencing factors of survival ( < 0.05). The overall effective rate of the research group was higher ( < 0.05). The incidence of adverse reactions in the study group was lower ( < 0.05). The levels of Hb, red blood cell count, and HCT in the study group were higher ( < 0.05). Compared with the control group, the SPO2 level and the red blood cell deformability index were higher in the study group ( < 0.05). After blood transfusion, the level of (diphosphoglycerate) DPG in the study group was higher than that in the control group ( < 0.05). The length of hospital stay in the study group was significantly shortened ( < 0.05). The nosocomial infection rate and case fatality rate in the study group were significantly reduced ( < 0.05).

Conclusion: Red blood cell storage time ≤ 14 d, LYM% < 12%, LDH > 500 U/L, and ALB < 30 g/L are all significantly correlated with survival time. KPS < 30, delirium, LDH > 500 U/L, and ALB < 30 g/L were independent factors for survival ( < 0.05). Transfusion of red blood cells stored for ≤14 days in patients with advanced malignant tumors can significantly increase the effective infusion rate, improve anemia status, shorten hospital stay, and reduce mortality and risk of nosocomial infection and is worthy of clinical promotion.

Citing Articles

Retracted: Effect of Hematocrit Injury on the Survival Rate of Advanced Malignant Tumors and Its Clinical Significance.

Methods In Medicine C Comput Math Methods Med. 2023; 2023:9784208.

PMID: 38094325 PMC: 10718686. DOI: 10.1155/2023/9784208.

References

Liu K, Zhang X, Xu W, Chen J, Yu J, Gamble J . Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply. Clin Transl Gastroenterol. 2017; 8(6):e98. PMC: 5518951. DOI: 10.1038/ctg.2017.28. View

Beal E, Tsung A, McAlearney A, Gregory M, Nyein K, Scrape S . Evaluation of Red Blood Cell Transfusion Practice and Knowledge Among Cancer Surgeons. J Gastrointest Surg. 2021; 25(11):2928-2938. DOI: 10.1007/s11605-020-04899-7. View

Heddle N, Cook R, Arnold D, Liu Y, Barty R, Crowther M . Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. N Engl J Med. 2016; 375(20):1937-1945. DOI: 10.1056/NEJMoa1609014. View

Pan Y, Mei J, Chen J, Zhang D, Wang J, Wang X . Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma. Ann Surg Oncol. 2021; 29(3):2016-2029. DOI: 10.1245/s10434-021-10903-4. View

Lu W, Jin X, Yang C, Du P, Jiang F, Ma J . Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trial. Cancer Biol Ther. 2017; 18(6):433-438. PMC: 5536939. DOI: 10.1080/15384047.2017.1323589. View

Carson J, Guyatt G, Heddle N, Grossman B, Cohn C, Fung M . Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016; 316(19):2025-2035. DOI: 10.1001/jama.2016.9185. View

Liang Q, Tang X, Yu J, Xiong M, Zhu H, Xiong L . Clinical observation of Yiqi Qingdu prescription on the treatment of intermediate-stage and advanced non-small-cell lung cancer. J Tradit Chin Med. 2021; 41(2):308-315. View

Koch C, Li L, Sessler D, Figueroa P, Hoeltge G, Mihaljevic T . Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008; 358(12):1229-39. DOI: 10.1056/NEJMoa070403. View

Tanaka S, Kawaguchi Y, Kubo S, Kanazawa A, Takeda Y, Hirokawa F . Validation of index-based IWATE criteria as an improved difficulty scoring system for laparoscopic liver resection. Surgery. 2018; 165(4):731-740. DOI: 10.1016/j.surg.2018.10.012. View

10.

Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, Ddungu H, Kyeyune D, Musisi E . Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia: The TOTAL Randomized Clinical Trial. JAMA. 2015; 314(23):2514-23. DOI: 10.1001/jama.2015.13977. View

11.

Wang D, Sun J, Solomon S, Klein H, Natanson C . Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion. 2011; 52(6):1184-95. PMC: 3883449. DOI: 10.1111/j.1537-2995.2011.03466.x. View

12.

Tanhehco Y . Red Blood Cell Transfusion. Clin Lab Med. 2021; 41(4):611-619. DOI: 10.1016/j.cll.2021.07.004. View

13.

Weinberg J, McGwin Jr G, Vandromme M, Marques M, Melton S, Reiff D . Duration of red cell storage influences mortality after trauma. J Trauma. 2010; 69(6):1427-31. PMC: 3136808. DOI: 10.1097/TA.0b013e3181fa0019. View

14.

Liu X, Xiu L, Jiao J, Zhao J, Zhao Y, Lu Y . Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: a retrospective clinical analysis. J Integr Med. 2017; 15(6):469-475. DOI: 10.1016/S2095-4964(17)60377-7. View

15.

Fergusson D, Hebert P, Hogan D, LeBel L, Rouvinez-Bouali N, Smyth J . Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA. 2012; 308(14):1443-51. DOI: 10.1001/2012.jama.11953. View

16.

Chan C, Chen F, Hsueh K, Hsiao Y . The Effect of Hypoxia on Relative Biological Effectiveness and Oxygen Enhancement Ratio for Cells Irradiated with Grenz Rays. Cancers (Basel). 2022; 14(5). PMC: 8909589. DOI: 10.3390/cancers14051262. View

17.

Kimura H, Ohkawa K, Miyazaki M, Sakakibara M, Imanaka K, Tamura T . Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers. Hepatol Int. 2016; 11(1):105-114. DOI: 10.1007/s12072-016-9771-0. View

18.

Hod E, Brittenham G, Billote G, Francis R, Ginzburg Y, Hendrickson J . Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood. 2011; 118(25):6675-82. PMC: 3242722. DOI: 10.1182/blood-2011-08-371849. View

19.

Kudo M . Combination Cancer Immunotherapy with Molecular Targeted Agents/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma. Liver Cancer. 2019; 8(1):1-11. PMC: 6388565. DOI: 10.1159/000496277. View

20.

Steiner M, Ness P, Assmann S, Triulzi D, Sloan S, Delaney M . Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015; 372(15):1419-29. PMC: 5442442. DOI: 10.1056/NEJMoa1414219. View